Is BioVaxys Technology Corp. (BVAXF) a Buy, Sell, or Hold?
OTC : BVAXF
BioVaxys Technology Corp.
$0.0789 USD
$0 (0.0%)
- Volume
- 100
- Average Volume
- 40.72K
- Market Capitalization
- $2.3M
- P/E Ratio
- -0.91
- Dividend Yield
- 0.00%
- Price Target
- Year High
- $0.27
- Year Low
- $0.02
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $0.28
Company Overview
OTC
James Christopher Passin
Biotechnology
Healthcare
BVAXF
3
CA
USD
Liquidity Metrics
-0.04
0.28
0.28
0.00
0.00
Sales & Valuation
-$
0.00
-0.56
-1.92
-0.04
Profitability
-$0.20199999999999999
-$3.95M
0.00%
0.00%
69.89%
-160.59%
P/E Metrics
-0.91
0.04
0.04
Analyst Price Target & Rating
0/5
0 Analysts
%
Financial Health Scores
-50.76
1/9
-$3.64M
$1.39M
$5.03M
-$5.51M
Key Metrics (TTM)
$2.17M
0.00
-0.99
0.28
69.89%
61.28%
-109.12%
-52.18%
0 days
Company Executives
| Name | Title |
|---|---|
| Christopher Cherry | Chief Financial Officer |
| James Christopher Passin | Co-Founder, Chief Executive Officer, & Director |
| Kenneth E. Kovan | Co-Founder, President & Chief Operating Officer |
| David Berd | Co-Founder & Chief Medical Officer |
Poll Results
No votes yet today — be the first to share your view!
About BioVaxys Technology Corp. (OTC:BVAXF) Stock
BioVaxys Technology Corp. (BVAXF) is a clinical-stage biotechnology company primarily engaged in the development of innovative vaccine platforms targeting both antiviral diseases and various forms of cancer. Its product pipeline features several key candidates, including two SARS-CoV-2 vaccines: BVX-0320, a monovalent version, and BVX-0121, a multivalent option. In the oncology space, BioVaxys is advancing BVX-0918A, a haptenized tumor cell vaccine designed for ovarian cancer, and BVX-0918C, aimed at cervical cancer. The company also has programs addressing Human Papillomavirus (HPV), such as Papilocare for HPV-dependent cervical lesions and the BVX-0204 HPV viral vaccine. Furthermore, BioVaxys offers CoviDTH, an immunodiagnostic tool developed to detect immune system responses in individu ... als previously exposed to SARS-CoV-2. To support its development initiatives, BioVaxys has established several strategic collaborations. It holds a bioproduction agreement with WuXi Biologics Limited for the manufacturing of SARS-CoV-2 s-proteins, crucial components for BVX-0320 and CoviDTH. The company also has a research collaboration for BVX-0320 with The Ohio State University, Wexner School of Medicine. Additionally, Bioanalytical Systems, Inc. is conducting preclinical toxicology studies for BioVaxys' CoviDTH immunodiagnostic under a separate agreement. The company's operations are headquartered in Vancouver, Canada.
Frequently Asked Questions
-
What is the current BioVaxys Technology Corp. (BVAXF) stock price?
-
BioVaxys Technology Corp.(OTC:BVAXF) stock price is $0.0789 in the last trading session. During the trading session, BVAXF stock reached the peak price of $0.267 while $0.0209 was the lowest point it dropped to. The percentage change in BVAXF stock occurred in the recent session was 0.0% while the dollar amount for the price change in BVAXF stock was $0.
-
BVAXF's industry and sector of operation?
-
The OTC listed BVAXF is part of Biotechnology industry that operates in the broader Healthcare sector.
-
Who are the executives of BVAXF?
-
Christopher Cherry | Chief Financial Officer
James Christopher Passin | Co-Founder, Chief Executive Officer, & Director
Kenneth E. Kovan | Co-Founder, President & Chief Operating Officer
David Berd | Co-Founder & Chief Medical Officer
| -
How many employees does BVAXF have?
-
Number of BVAXF employees currently stands at 3. BVAXF operates from 146 Thirtieth Street, Etobicoke, ON M8W 3D4, CA.
-
Link for BVAXF official website?
-
Official Website of BVAXF is: https://www.biovaxys.com
-
How do I contact BVAXF?
-
BVAXF could be contacted at phone #646 452 7054 and can also be accessed through its website. BVAXF operates from 146 Thirtieth Street, Etobicoke, ON M8W 3D4, CA.
-
How many shares of BVAXF are traded daily?
-
The average number of BVAXF shares traded daily for last 3 months was 40.72K.
-
What is the market cap of BVAXF currently?
-
The market value of BVAXF currently stands at $2.3M with its latest stock price at $0.0789